市場調查報告書
商品編碼
1097148
製藥機器人市場規模、份額、趨勢分析報告:2022~2030產品(傳統機器人、協作機器人)、應用(揀選和包裝、實驗室應用)、最終應用、地區細分市場預測Pharmaceutical Robots Market Size, Share & Trends Analysis Report By Product (Traditional Robots, Collaborative Robots), By Application (Picking & Packaging, Laboratory Applications), By End-use, By Region, And Segment Forecasts, 2022 - 2030 |
根據 Grand View Research, Inc. 的最新報告,預計到 2030 年,全球製藥機器人市場規模將達到 3.579 億美元。
從 2022 年到 2030 年,市場預計將以 9.2% 的複合年增長率增長。隨著製藥業的發展和產量和產品質量的提高,生產靈活性的提高,空間利用率的降低,工人流動率的降低,運營成本的降低,以及機器人系統在產品製造中提供的健康. 許多好處,包括提高安全性、減少生產停機時間和改進廢物管理,正在推動這些產品的採用並推動市場增長。
根據 Mint 於 2020 年 4 月發表的一篇文章,印度 13 億多人口的醫護人員數量很少,因此儘管價格很高,但它可以用於所有類型的醫療保健環境。預計機器人技術的使用將會增加。 COVID-19 大流行正在為市場打開機會。希望利用其在北美和歐洲的前景的製藥公司越來越多地轉向機器人。根據機器人工業協會(IRA)的數據,與 2019 年相比,2020 年北美生命科學公司的機器人訂單增加了 69%。
隨著 COVID-19 的爆發,製藥行業正在增加使用機器人來優化程序。機器人將部署在北美和歐洲,以降低流程成本和復雜性。最近,作為解決因生產延遲而導致的藥品短缺的解決方案,引起了人們的關注。製藥公司預計將與機器人解決方案提供商合作,將機器人技術納入其製造、藥物開發和防偽程序。隨著公司增加對製藥領域的投資,未來幾年機器人的使用可能會增加。
2021 年,由於傳統機器人產品在物料搬運、揀選、包裝、碼垛和檢驗方面的應用越來越廣泛,其收入份額將最大。預計協作機器人將在預測區間內記錄最快的增長率。許多公司正在用協作機器人和協作機器人(人機組合)取代傳統機器人。協作機器人之所以被廣泛採用,是因為它們將機器人的重複性任務與人類的個人技能相結合,以簡化製造過程。此外,這些機器比傳統機器更便宜,更易於操作和維護。
2021 年,揀選和包裝應用領域將佔據最大的收入份額,預計在預測期內將呈現最快的增長。這種增長可能主要是由於對個性化包裝的高需求以及與該細分市場相關的好處,例如快速、高效的追蹤和空間的最佳利用。此外,所有傳統的機器人解決方案主要用於揀選和包裝。例如,Denso Wave Incorporated 開發的 VP-6242G 和 VS-068A2 等 6 軸多關節機器人可實現揀選和包裝。
預計 2021 年,製藥公司的最終用途板塊在預測期內的收入份額最大,增長率最快。這是由於機器人技術在藥物發現和開發中的使用越來越多。製藥公司也參與了個性化醫療的開發,這進一步推動了該領域的增長。實驗室將在預測間隔期間顯著增長,以利用這些自動化解決方案執行重複性任務(例如藥物發現活動中的體外和液體運動)的能力來提高一致性和準確性。
2021 年,預計亞太地區將主導市場,並在預測期內創下最快的增長率。對藥品生產的需求不斷增加,以及為製藥公司開髮用於執行高速、降低污染風險、準確性和優化空間利用等任務的機器人機器,正在推動該地區的市場增長。此外,越來越多的政府舉措增加了工業機器人的採用率,進一步推動了區域市場的增長。例如,2016年,中國政府啟動了《機器人產業發展規劃(2016-2020年)》,旨在推動機器人在更廣泛領域的應用和吸引外資,到2020年將採用國產技術進行生產。目標是每年發展10萬台工業機器人。
The global pharmaceutical robots market size is expected to reach USD 357.9 million by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 9.2% from 2022 to 2030. The growing pharmaceutical industry and numerous benefits offered by robotic systems in product manufacturing, such as improved production output and product quality, increased production flexibility, lesser space utilization, no labor turnover, low operating costs, enhanced health and safety, reduced production downtime, and better waste management, are driving the adoption of these products, thereby aiding the market growth.
According to an article published by Mint in April 2020, the adoption and usage of robotic technology are expected to increase in India across all types of healthcare settings, despite their high prices, owing to the availability of a smaller number of healthcare professionals for more than 1.3 billion population. The market is seeing opportunities due to the COVID-19 pandemic. Pharmaceutical companies looking to capitalize on prospects in North America and Europe are increasingly turning to robots. According to the Robotic Industries Association (IRA), orders for robots from North American life science companies increased by 69% in 2020 compared to 2019.
The COVID-19 outbreak has prompted the pharmaceutical industry to increase its use of robots to optimize procedures. Robots will continue to be deployed in North America and Europe to cut the process's costs and complexity. It has recently gained interest as a solution to medicine shortages caused by production delays. Pharmaceutical companies are anticipated to form partnerships with robotics solution providers to incorporate robotics into manufacturing, medication development, and anti-counterfeiting procedures. As companies increase their investments in the pharmaceutical sector, the use of robots may grow in the coming years.
In 2021, the traditional robots product segment accounted for the largest revenue share owing to its increasing adoption in material handling, picking and packaging, palletizing, and inspection. Collaborative robots are anticipated to register the fastest growth rate during the forecast period. Many companies are replacing traditional with collaborative robots or cobots, which is a combination of humans and robotics. The adoption of cobots is significantly increasing as they combine repetitive tasks of robots and the individual skills of humans to bring in efficiency in manufacturing processes. These machines are also cheaper and easier to operate and maintain as compared to the traditional ones.
In 2021, the picking and packaging application segment accounted for the largest revenue share and is anticipated to witness the fastest growth during the forecast period. This growth can mainly be attributed to the high demand for personalized packaging and benefits associated with this segment, including high speed, efficient track and trace, and optimum utilization of the floor space. In addition, all the traditional robotic solutions are mainly used for picking and packaging. For instance, 6-axis articulated robots such as VP-6242G and VS-068A2 developed by Denso Wave Incorporated enable picking and packaging.
In 2021, the pharmaceutical companies end-use segment accounted for the largest revenue share and is anticipated to register the fastest growth rate during the forecast period. This is attributed to the increasing usage of robotics in drug discovery and development. In addition, pharmaceutical companies are involved in developing personalized medicine, which further supports the growth of the segment. Research laboratories are anticipated to witness significant growth during the forecast period owing to the ability of these automated solutions to perform repetitive tasks, such as moving test tubes and fluids, during drug discovery-related activities, facilitating a high rate of consistency and accuracy.
In 2021, Asia Pacific dominated the market and is anticipated to register the fastest growth rate during the forecast period. The rise in the demand for the production of drugs and the development of robotic machines for performing tasks with high speed, reduced risk of contamination, accuracy, and optimum utilization of space among pharmaceutical companies is boosting the regional market growth. Moreover, a rise in the number of initiatives undertaken by the government to increase the adoption of industrial robots is further aiding the regional market growth. For instance, in 2016, the Chinese government launched the Robotics Industry Development Plan (2016-2020), aimed at promoting robot applications to a wider range of fields and attracting foreign investment, to develop 100,000 industrial robots produced by domestic technology annually by 2020.